# XGen Pharmaceuticals DJB, Inc. – FDA Inspection, Jun 14, 2024

Source: https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/c5cd5149-0c5b-4980-8eb0-631d34b881ff
Source feed: FDA_Inspections

> FDA inspection 1233326 of XGen Pharmaceuticals DJB, Inc., June 14, 2024. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 314. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233326
- Company Name: XGen Pharmaceuticals DJB, Inc.
- Inspection Date: 2024-06-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1100288 - 2019-08-22](https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/d6b0670c-9dc4-4480-9916-340dd0ac3c7f)
- [FDA Inspection 1056541 - 2018-06-22](https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/b06c3904-011f-45d6-8c89-27ce5387c493)
- [FDA Inspection 1041478 - 2018-02-16](https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/68e925f6-2144-4752-b80c-f880b2ae982a)
- [FDA Inspection 954335 - 2015-12-23](https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/fc163fab-7c62-45f1-a5d6-85fe62e38051)
- [FDA Inspection 769993 - 2012-03-08](https://www.keypedia.com/records/fda_inspections/xgen-pharmaceuticals-djb-inc/ed8f5a68-6148-47d0-97da-e797fa028ef3)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jay-b-shah/c437fff9-807e-4dea-80c0-8f77850db6f8)

Company: https://www.keypedia.com/companies/xgen-pharmaceuticals-djb-inc/42cd8012-b30d-440e-b2c7-e0d2915c417a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c